Adoptive cell therapy involves collection of T cells or antigen-specific T cells from a patient or donor which are then genetically modified or expanded outside the body and given back to the patient to restore, augment or boost the immune system against cancer. It is an emerging method used for cancer treatment.
The global adoptive cell therapy market is estimated to be valued at US$ 6903.93 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period from 2024 to 2031.
Key players operating in the Adoptive Cell Therapy Market Demand are Broadcom, Celeno Communications, Infineon Technologies, Espressif Systems Shanghai Co Ltd, GCT Semiconductor Inc., I&C Technology, Intel Corporation, MediaTek, Inc., Microchip Technology Inc. Key players are involved in developing new treatment methods and conducting clinical trials of adoptive cell therapies for different cancer types.
The key opportunities in the adoptive cell therapy market include research on combination therapies using cell therapies with chemotherapy or immunotherapy. This offers potential to enhance clinical outcomes. There is also scope for development of off-the-shelf allogeneic cell therapies using donor T cells that can benefit more patients.
Global expansion of the adoptive cell therapy market will be led by increasing investments in clinical trials across different regions. Increasing collaborations between biotech companies and academic institutions in developing countries also boosts research. Asia Pacific region will witness high growth owing to low-cost manufacturing and rising healthcare investments.
The major driver for adoptive cell therapy market is increasing success rates of cell therapies in cancer treatment. FDA approval of novel CAR T-cell therapies like Kymriah and Yescarta for leukemia has boosted confidence in this approach. Rising incidence of cancers due to growth in risk factors like smoking and obesity also increases the need for improved treatment methods. Growing awareness among patients about innovative treatment options and their willingness to try cell-based therapies further supports the market growth.
Political: Adoptive cell therapy market is regulated by regulatory bodies that govern cell and gene therapy research and development. Their policies influence the development and adoption of new therapies.
Economic: Rising healthcare budgets and growing demand for personalized medicine are driving investments in adoptive cell therapy research. However, high costs associated with development and production may hinder widespread adoption.
Social: Increasing awareness about adoptive cell therapy and rising demand for effective treatments for cancer and other diseases are positively impacting the market. Concerns remain regarding the affordability and long-term safety of these new therapies.
Technological: Advancements in molecular engineering, immunotherapy, and gene editing techniques are enabling development of more targeted and effective adoptive cell therapies. Automation technologies are helping reduce production costs. Clinical research is expanding applications to new disease indications.
North America currently holds the largest share of the Global Adoptive Cell Therapy Market Demand, driven by presence of major players and advanced healthcare infrastructure to support clinical research and adoption of new therapies.
Fastest Growing Region
Asia Pacific is poised to be the fastest growing regional market over the forecast period. This is attributed to rising healthcare expenditure, growing incidences of cancer and other target diseases, expanding clinical research, and increasing collaborations between regional and international industry players.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it